Skip to content

Cardiovascular and Psychological Consequences of COVID-19

Cardiovascular and Psychological Consequences of COVID-19

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05758649
Enrollment
104
Registered
2023-03-07
Start date
2020-10-01
Completion date
2024-02-29
Last updated
2024-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-COVID Conditions

Brief summary

The study will assess cardiac and psychological profile at 2-3 months after recovery from COVID-19 infection.

Detailed description

A significant proportion of patients hospitalized for COVID-19 showed laboratory signs of myocardial damage, detected by elevated troponin levels, and these were associated with more severe clinical course and higher mortality. Moreover, it is unknown how the health emergency and the associated conditions may have influenced and still influence the psychological experience of the affected people. Thus, in order to promote continuity of care, post-COVID-19 disease clinics have therefore been activated dedicated to a specific follow-up program for monitoring long-term alterations and for the early identification of patients requiring rehabilitation. The program includes a first follow-up visit (2-3 months after recovery) including cardiac (2D-echocardiography, six-minute walking test, autonomic function evaluation) and psychological (Patient Health Questionnaire-9 (PHQ-9) Generalized Anxiety Disorder-7 (GAD) National Stressful Events Survey PTSD Short Scale (NSESSS)) evaluation. A second follow-up visit will be performed at 12 months in the form of structured interview,

Interventions

None listed

Sponsors

Istituti Clinici Scientifici Maugeri SpA
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Recent discharge (≤ 3 months) from a COVID+ ward for SARS-CoV-2 disease

Exclusion criteria

* Serious clinical conditions (severe chronic inflammatory diseases, neoplasms, neurological pathologies). * Non-Italian education, illiteracy, or return to illiteracy. * Severe visual-perceptual deficits. * Low motivation/interest or refusal to undergo the assessment.

Design outcomes

Primary

MeasureTime frame
prevalence of patients with cardiovascular or psychological sequelae3 months

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026